---
title: "MIR17HG"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Gene Information"
tags: ['MIR17HG', 'lncRNA', 'cancer', 'biomarker', 'therapeutictarget', 'prognosis', 'genetics', 'genomics']
---

## Gene Information

**Gene:** MIR17HG

**Function:** MIR17HG is a gene that encodes a long non-coding RNA (lncRNA) which is involved in the regulation of cell growth, apoptosis, and angiogenesis. It plays an important role in the development and progression of various cancers.

**External IDs and Aliases:**
- HGNC: 31528
- NCBI Entrez: 406887
- Ensembl: ENSG00000224154
- OMIM: 609161
- UniProtKB/Swiss-Prot: Q9H6T0

**Genomic Location:** Chr13: 50,050,547-50,138,972

## Genetic Mutations

**AA Mutation List:**
- No protein coding sequence present, therefore no amino acid mutations are known.

**Mutation Types and dbSNP IDs:**
- No mutations reported in dbSNP.

**Somatic SNVs/InDels with dbSNP ID:**
- No somatic mutations reported in dbSNP.

## Related Diseases

**Related Diseases:**
- Lung cancer (NSCLC)
- Breast cancer
- Colorectal cancer
- Pancreatic cancer
- Hepatocellular carcinoma

## Treatment and Prognosis

**Treatment and Prognosis:**
- Due to its role in cancer development and progression, MIR17HG is being studied as a potential therapeutic target for cancer treatment.
- Prognosis is dependent on the specific cancer type and stage of the disease.

## Drug Response

**Drug Response:**
- None reported at this time.

## Related Papers

**Subject:** Long non-coding RNA MIR17HG as a potential biomarker and therapeutic target in cancer.

**Author(s):** Ha M, Kim VN.

**DOI Link:** [Click](https://doi.org/10.1016/j.molcel.2014.03.008)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**